Evidence map›Paper›PMID 40799820›Full record

ReviewFrontiers in pharmacology2025

Research progress on heteroterpene and meroterpenoid compounds from the

Jingxin Mao, Meiyan Yang, Tingting Li, Yan Sun, Zhaoyue Dong, Honghong Zhan, Min Chen

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jingxin MaoChongqing Key Laboratory of High Active Traditional Chinese Drug Delivery system, Chongqing Medical and Pharmaceutical College, Chongqing, China.
Meiyan YangChongqing Key Laboratory of New Drug Screening from Traditional Chinese Medicine, Integrative Science Center of Germplasm Creation in Western China (Chongqing) Science City and Southwest University, Chongqing, China.
Tingting LiChongqing Key Laboratory of High Active Traditional Chinese Drug Delivery system, Chongqing Medical and Pharmaceutical College, Chongqing, China.
Yan SunChongqing Key Laboratory of New Drug Screening from Traditional Chinese Medicine, Integrative Science Center of Germplasm Creation in Western China (Chongqing) Science City and Southwest University, Chongqing, China.
Zhaoyue DongChongqing Key Laboratory of New Drug Screening from Traditional Chinese Medicine, Integrative Science Center of Germplasm Creation in Western China (Chongqing) Science City and Southwest University, Chongqing, China.
Honghong ZhanChongqing Key Laboratory of New Drug Screening from Traditional Chinese Medicine, Integrative Science Center of Germplasm Creation in Western China (Chongqing) Science City and Southwest University, Chongqing, China.
Min ChenChongqing Key Laboratory of High Active Traditional Chinese Drug Delivery system, Chongqing Medical and Pharmaceutical College, Chongqing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The plant genus,

Indexed as

analysesbiological activitiesphytochemistryRhododendron genustraditional Chinese medicines

Identifiers

PMID40799820
PMCPMC12339509

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.